本文旨在介紹臺灣性別醫學發展。性別醫學在國際上是由醫學界人發起，臺灣卻是由一群社會科學、公衛與護理學界的性別研究者開始發起，之後從中央公部門推動醫學研究納入性別分析與醫學教育融入性別觀點。經歷二十多年的努力，國防醫學院及三軍總醫院一群醫師於2022年9月27日成立「臺灣性別醫學學會」(TGMS)，其宗旨為促進臺灣性別醫學之發展。TGMS以舉辦國內外相關學術演講，以及運用季刊會訊，發表性別醫學文章等方式逐漸建立臺灣性別醫學新知。該學會已辦理三次全國活動，討論性別醫學在國際與臺灣的發展、性別醫學倫理、性別醫學研究指引、醫學教育、高血壓、紅斑性狼瘡、腦中風、老年醫學等議題，啟發國內醫學領域對於性別醫學的瞭解及興趣。2023臺灣性別醫學學會年會特別邀請日本性差醫學學會秋下雅弘教授(Dr. Masahiro Akishita)，以及美國史丹佛大學(Stanford University)Pro. Londa Schiebinger演講，獲得許多醫學界人士參與。會訊目前已經出刊五期，共發表15篇精彩的性別醫學文章。期待TGMS未來能促進臺灣性別醫學的進步與創新，最終提高整體醫療質量和病人福祉。

This article explores the development of gender medicine in Taiwan. While gender medicine internationally has its roots in the medical community, in Taiwan, it was initiated by gender researchers from the social sciences, public health, and nursing. Later, the central government promoted the integrating of gender analysis into medical research and the incorporating gender perspectives into medical education. On September 27, 2022, after more than two decades of effort, doctors from the National Defense Medical Center and the Tri-Service General Hospital established The Taiwanese Association for Gender Medicine (TGMS) to advance gender medicine in Taiwan. TGMS has been building a body of knowledge by organizing academic lectures, both domestically and internationally, and publishing articles in its quarterly newsletter. To date, the association has held three national events covering various topics, including the development of gender medicine internationally and in Taiwan, ethics in gender medicine, research guidelines, medical education, hypertension, lupus, stroke, and geriatric medicine. These events have ignited interest and understanding of gender medicine within Taiwan's medical community. In its 2023 annual meeting, TGMS invited distinguished speakers, including Dr. Masahiro Akishita from the Japan Association for Gender-Specific Medicine and Professor Londa Schiebinger from Stanford University. The association’s newsletter has published five issues, presenting 15 insightful articles on gender medicine. TGSM aims to foster progress and innovation in gender medicine in Taiwan, ultimately enhancing overall healthcare quality and patient welfare.